44 Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$817K Hold
888
0.29% 114
2025
Q4
$954K Sell
888
-295
-25% -$282K 0.32% 100
2025
Q3
$903K Sell
1,183
-36
-3% -$26.8K 0.31% 104
2025
Q2
$950K Sell
1,219
-394
-24% -$306K 0.34% 98
2025
Q1
$1.33M Sell
1,613
-171
-10% -$142K 0.5% 69
2024
Q4
$1.38M Sell
1,784
-244
-12% -$202K 0.53% 59
2024
Q3
$1.83M Buy
+2,028
New +$1.82M 0.64% 51
2023
Q2
$948K Buy
2,021
+483
+31% +$203K 0.32% 75
2023
Q1
$528K Hold
1,538
0.18% 105
2022
Q4
$563K Buy
1,538
+805
+110% +$285K 0.19% 100
2022
Q3
$237K Buy
733
+37
+5% +$11.7K 0.1% 150
2022
Q2
$226K Buy
+696
New +$209K 0.09% 157
2021
Q3
Sell
-8,562
Closed -$1.97M 179
2021
Q2
$1.97M Buy
+8,562
New +$1.72M 0.76% 37
2021
Q1
Sell
-1,778
Closed -$300K 172
2020
Q4
$300K Buy
+1,778
New +$265K 0.14% 120

Other funds holding LLY

44 Wealth Management's LLY Position: Q1 2026 in Review

44 Wealth Management held its Eli Lilly (LLY) position steady in Q1 2026 at 888 shares worth $817K. The position accounts for 0.29% of the portfolio, ranked #114.

44 Wealth Management first reported a position in LLY in Q4 2020 and has held it in 14 quarters since. The position peaked at $1.97M in Q2 2021. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • 44 Wealth Management held 888 shares of Eli Lilly worth $817K as of Q1 2026.
  • 44 Wealth Management left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.29% of 44 Wealth Management's portfolio in Q1 2026, its #114 holding.
  • 44 Wealth Management first reported a position in Eli Lilly in Q4 2020 and has held it in 14 quarters since.
  • 44 Wealth Management's Eli Lilly position peaked at $1.97M in Q2 2021.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on 44 Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.